India’s healthcare technology sector has gained international attention with iOncology.ai, an Indian artificial intelligence platform being developed for cancer care, featured in The BRICS Health Journal.

The platform is being developed through a collaboration between AIIMS New Delhi and C-DAC Pune, with support from the Ministry of Electronics and Information Technology. Its inclusion in the BRICS Health Journal highlights India’s growing focus on using artificial intelligence to address complex healthcare challenges.

iOncology.ai: Bringing AI into Cancer Care

iOncology.ai is designed as a clinical support platform that can help healthcare professionals work with different types of cancer-related information.

Its potential applications include early cancer detection, risk assessment, treatment planning, multidisciplinary case review and long-term patient management.

The platform uses Indian clinical, radiological and histopathological datasets. Future development plans include integrating genetic information and electronic health records, which could help create a more connected approach to cancer care.

Importantly, the platform is currently undergoing clinical validation and should not be considered a replacement for doctors or established cancer diagnostic methods.

Why Artificial Intelligence Matters in Oncology

Cancer care involves large amounts of medical information, including pathology reports, radiology scans, laboratory results, treatment history and follow-up records.

AI can help healthcare professionals process such information and identify patterns that may support clinical decision-making. Across the world, researchers are exploring AI applications in cancer screening, diagnosis, treatment planning and patient monitoring.

For countries with large and diverse populations, locally developed AI systems may also help address specific healthcare requirements.

India’s Role in BRICS Healthcare Innovation

The BRICS Health Journal feature places iOncology.ai within the broader discussion about healthcare innovation in emerging economies.

BRICS countries face significant challenges related to cancer prevention, early detection, specialist availability and access to advanced healthcare services. Digital health and AI are increasingly being explored as potential tools to strengthen healthcare systems.

India’s development of iOncology.ai demonstrates how institutions such as AIIMS and C-DAC are working to create technology focused on Indian healthcare data and requirements.

The Future of AI in Cancer Care

The future impact of iOncology.ai will depend on clinical validation, real-world implementation, data quality, interoperability and patient-data protection.

If successfully validated, AI-based platforms could potentially support doctors by making complex patient information easier to analyse and helping improve coordination across different stages of cancer care.

The feature in The BRICS Health Journal represents an important opportunity to showcase India’s healthcare AI research internationally. It also reflects the growing conversation around how emerging economies can develop locally relevant digital solutions for major public-health challenges.

As AI continues to evolve, technologies such as iOncology.ai could become part of a broader digital healthcare ecosystem—while keeping clinical expertise and patient care at the centre.